Streptococcus Pneumoniae

A vaccine discovery and development company on March 18 announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston.

Dr. Emilio Emini

WASHINGTON — Pfizer Inc's next-generation Prevnar vaccine missed some of the main goals in a study testing its ability to protect against bacteria that cause ear infections, pneumonia and other diseases.

Sharon Hillier

An early clinical study shows that a vaccine to prevent Group B Streptococcus infection is safe and modestly effective, according to findings presented Oct. 30 at the annual meeting of the Infectious Diseases Society of America.